Chelsea Therapeutics International chelseatherapeutics.com


Chelsea Therapeutics (Nasdaq:CHTP) is a biopharmaceutical company that seeks to acquire, develop and commercialize innovative products for the treatment of a variety of human diseases that address important unmet medical needs or offer alternatives to current methods of treatment.

Chelsea Therapeutics (Nasdaq:CHTP) is a biopharmaceutical company that seeks to acquire, develop and commercialize innovative products for the treatment of a variety of human diseases that address important unmet medical needs or offer alternatives t...Show all

Company (Acquired)

Phone: 704-341-1516

Fax:

3530 Toringdon Way
Suite 200
Charlotte, 28277
North Carolina, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Chelsea Therapeutics International $66.9M Jun 23, 2014

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Chelsea Therapeutics International Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 10 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Threo-dops controlled release formulation May 10, 2013 Mar 03, 2015 Patent
Antifolate combinations Dec 07, 2011 Feb 25, 2014 Patent
Enzyme inhibiting compounds Nov 04, 2010 Sep 10, 2013 Patent
Anthranilic acid derivatives Jul 17, 2012 Jun 11, 2013 Patent
Threo-dops controlled release formulation Mar 13, 2012 Jun 11, 2013 Patent
See all 15 patents